|
Treatment of Craniofacial Pain Disorders
This invention uses the gene-editing technique CRISPR/Cas9 to target pain-related proteins in the trigeminal ganglion. This editing was shown to inhibit migraine-like pain in female mice and has potential to treat craniofacial pain disorders and has long-lasting analgesic effects.
Background:
Many people suffer from craniofacial pain disorders, with...
Published: 7/15/2022
|
Inventor(s): Frank Porreca, Edita Navratilova, Aubin Moutal, Rajesh Khanna
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios
|
